Free Trial

IM Cannabis (IMCC) Stock Price, News & Analysis

IM Cannabis logo
$2.44 +0.18 (+7.96%)
Closing price 03:58 PM Eastern
Extended Trading
$2.45 +0.01 (+0.41%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About IM Cannabis Stock (NASDAQ:IMCC)

Key Stats

Today's Range
$2.23
$2.61
50-Day Range
$2.18
$3.55
52-Week Range
$1.29
$7.12
Volume
80,841 shs
Average Volume
113,336 shs
Market Capitalization
$12.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IM Cannabis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

IMCC MarketRank™: 

IM Cannabis scored higher than 24% of companies evaluated by MarketBeat, and ranked 854th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for IM Cannabis.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IM Cannabis is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IM Cannabis is -4.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    IM Cannabis has a P/B Ratio of 4.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about IM Cannabis' valuation and earnings.
  • Percentage of Shares Shorted

    0.34% of the float of IM Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    IM Cannabis has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IM Cannabis has recently decreased by 46.43%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    IM Cannabis does not currently pay a dividend.

  • Dividend Growth

    IM Cannabis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.34% of the float of IM Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    IM Cannabis has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IM Cannabis has recently decreased by 46.43%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    IM Cannabis has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for IM Cannabis this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for IMCC on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added IM Cannabis to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IM Cannabis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.91% of the stock of IM Cannabis is held by insiders.

  • Percentage Held by Institutions

    Only 7.68% of the stock of IM Cannabis is held by institutions.

  • Read more about IM Cannabis' insider trading history.
Receive IMCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMCC Stock News Headlines

IM Cannabis (NASDAQ:IMCC) Rating Lowered to Hold at Wall Street Zen
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
See More Headlines

IMCC Stock Analysis - Frequently Asked Questions

IM Cannabis' stock was trading at $2.33 at the beginning of 2025. Since then, IMCC stock has increased by 4.9% and is now trading at $2.4450.

IM Cannabis Corp. (NASDAQ:IMCC) released its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.07. The firm earned $9.21 million during the quarter, compared to analyst estimates of $12.88 million. IM Cannabis had a negative trailing twelve-month return on equity of 59.80% and a negative net margin of 4.19%.

IM Cannabis's stock reverse split before market open on Friday, July 12th 2024.The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Top institutional shareholders of IM Cannabis include Heron Bay Capital Management (1.95%).

Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), GE Aerospace (GE) and AppLovin (APP).

Company Calendar

Last Earnings
8/12/2025
Today
8/28/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMCC
CIK
1792030
Fax
N/A
Employees
340
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.72 million
Net Margins
-4.19%
Pretax Margin
-4.55%
Return on Equity
-59.80%
Return on Assets
-5.15%

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
0.72
Quick Ratio
0.62

Sales & Book Value

Annual Sales
$39.44 million
Price / Sales
0.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.56 per share
Price / Book
4.37

Miscellaneous

Outstanding Shares
5,250,000
Free Float
4,937,000
Market Cap
$12.84 million
Optionable
Not Optionable
Beta
2.20
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:IMCC) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners